Scopus Asset Management’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-132,982
Closed -$9.71M 273
2022
Q4
$9.71M Sell
132,982
-275,000
-67% -$21.7M 0.26% 127
2022
Q3
$34M Buy
407,982
+150,000
+58% +$12.9M 1.26% 15
2022
Q2
$20.6M Sell
257,982
-371,999
-59% -$36.1M 1.13% 28
2022
Q1
$65.5M Buy
629,981
+265,000
+73% +$22M 1.62% 5
2021
Q4
$27.4M Sell
364,981
-189,999
-34% -$13.3M 0.59% 51
2021
Q3
$36M Buy
554,980
+70,000
+14% +$4.28M 0.61% 47
2021
Q2
$29.4M Buy
+484,980
New +$28.7M 0.38% 81
2019
Q2
Sell
-357,079
Closed -$18.8M 207
2019
Q1
$18.8M Buy
357,079
+190,963
+115% +$9.95M 0.55% 67
2018
Q4
$7.81M Sell
166,116
-12,134
-7% -$633K 0.51% 70
2018
Q3
$10.3M Buy
178,250
+106,250
+148% +$5.88M 0.14% 153
2018
Q2
$3.92M Buy
+72,000
New +$3.57M 0.04% 259

Other funds holding NTR

Scopus Asset Management's NTR Position: Q1 2023 in Review

Scopus Asset Management sold out of Nutrien (NTR) in Q1 2023, closing a stake of 132,982 shares — an estimated $9.71M sold.

Scopus Asset Management first reported a position in NTR in Q2 2018 and held it in 11 quarters. The position peaked at $65.5M in Q1 2022. 666 funds tracked by Wall St. Rank hold NTR as of Q1 2023.

  • Scopus Asset Management reported no remaining Nutrien position as of Q1 2023 after selling out during the quarter.
  • Scopus Asset Management sold 132,982 Nutrien shares in Q1 2023, an estimated $9.71M.
  • Scopus Asset Management first reported a position in Nutrien in Q2 2018 and held it in 11 quarters.
  • Scopus Asset Management's Nutrien position peaked at $65.5M in Q1 2022.
  • 666 funds tracked by Wall St. Rank held Nutrien as of Q1 2023.

Based on Scopus Asset Management's 13F filing for Q1 2023, filed 15 May 2023.